Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.
about
Incidence of Neutropenia in Veterans Receiving Lung Cancer Chemotherapy: A Comparison of Administrative Coding and Electronic Laboratory Data.Assessing patients' risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?A way forward on the medically appropriate use of white cell growth factorsRisk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice.Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia.Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study.Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.
P2860
Q33557215-7C5CAF9E-3081-42F4-B59C-E713BA663E1FQ36023851-3DB2DEFC-A885-4F6C-8F49-AF5D2C1B8B96Q36058245-989A4050-60EE-40B3-BCD3-AF389C6C8900Q36840636-A10512A2-96F9-4500-B1A3-346934FA5C4FQ38068457-6EF58DF6-EEA8-454F-A7F7-88A328EA8368Q38711166-B8EF5DD3-0FEA-4BE3-A93F-D36776D6B2DAQ39297322-06A26427-DEC9-4047-9502-C7F541E8BA14Q40829486-30C29CF4-CC3D-4463-94FB-A3E5E0D37001Q43026530-1E9C4A95-5307-451F-BE51-1CBA1BB5AE72Q47327831-1CB81FAA-29C6-4A64-82DE-F28A033CD9A9Q50042993-C6F28127-157B-4C72-96A1-862079CB1432
P2860
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Personalized medicine and canc ...... actor support of chemotherapy.
@en
Personalized medicine and canc ...... actor support of chemotherapy.
@nl
type
label
Personalized medicine and canc ...... actor support of chemotherapy.
@en
Personalized medicine and canc ...... actor support of chemotherapy.
@nl
prefLabel
Personalized medicine and canc ...... actor support of chemotherapy.
@en
Personalized medicine and canc ...... actor support of chemotherapy.
@nl
P2860
P356
P1476
Personalized medicine and canc ...... actor support of chemotherapy.
@en
P2093
Gary H Lyman
Nicole M Kuderer
P2860
P304
P356
10.1093/JNCI/DJR195
P407
P577
2011-06-13T00:00:00Z